New formulation of Zyprexa introduced for psychotic disorders and manic episodes Sep. 20, 2000 No Comments
Nebulized heparin reduces airways inflammation, improves spirometric parameters in asthma Sep. 14, 2000 No Comments
AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder Sep. 13, 2000 No Comments
Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program Sep. 8, 2000 No Comments